+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 10Years +
All Genders
ID06596746

Longitudinal Observational Study of Progression Markers in Neurodegenerative Diseases Using AI and Routine Clinical Data

Led by Casa di Cura San Raffaele Cassino · Updated on 2026-09-02

600

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a long-term observational study called MARKERS-NDD to collect data from patients with various neurodegenerative diseases. These diseases, including Parkinsons Disease, dementia, and related disorders, currently lack therapies that change their course. The study aims to improve early diagnosis and prediction of disease progression by analyzing clinical markers and using artificial intelligence to identify new diagnostic and prognostic indicators. Participants in MARKERS-NDD will be followed over 1 to 10 years during routine clinical visits. The study collects data from clinical evaluations, movement and gait analysis using motion capture and wearable sensors, brain imaging, neuropsychological and voice assessments, electroencephalography, and laboratory tests. AI-driven systems will analyze handwriting and voice patterns to detect motor and cognitive changes, supporting remote diagnosis and telemonitoring. Throughout participation, patients will undergo various assessments during normal care visits, including movement analysis, cognitive testing, brain imaging, and blood tests. Researchers will monitor and predict disease progression using these clinical markers along with AI models over up to 10 years. The study aims to develop tools to better understand neurodegenerative diseases and support their management through non-invasive, cost-effective methods.

CONDITIONS

Brief Title

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Research Team

M

Maria Francesca De Pandis, MD, PhD, Neurologist

M

Maria Gaglione

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here